The company's low P/S ratio may be due to expectations of limited future growth. Its underwhelming revenue outlook is a major contributor to its low P/S, forming a barrier for the share price.
The sale is a transformative divestiture for Triumph, delivering immediate value to the company and stakeholders. It's expected to accelerate Triumph's deleveraging progress and improve its market growth capacity.
Kim Fisk's appointment as COO is viewed positively due to her vast experience and successful history at Triumph. Her emphasis on service, product improvements, and innovation is anticipated to propel the company's future growth and success.
Triumph Group's price-to-sales ratio raises questions about its ability to maintain robust revenue growth, despite its recent price boost. This could reflect investors' doubts about the company's future performance vis-à-vis industry growth forecasts.
The flattening trend in Triumph Group's ROCE and the shrinkage of business indicate it's unlikely to become a multi-bagger stock. The market too doesn’t appear optimistic about the company's trends.
The aerospace parts maker$Triumph(TGI.US)$is furloughing about 2,300 workers in the U.S. and Europe, as the Boeing supplier deals with the shutdown of the jet maker’s commercial jet production.
Triumph股票討論區
專欄Today's pre-market stock movers: TGT, LOW, SONY, ROOT and more
• $National CineMedia(NCMI.US)$ +17.9% (AMC discloses 6.8% stake in NCMI)
• $MagnaChip Semiconductor(MX.US)$ +14.8% (report that private equity firms including Carlyle Group (CG) will bid for the company)
• $DLocal(DLO.US)$ +13.7% (In reaction to earnings)
• $SiriusPoint(SPNT.US)$ +8.2% (Chairman and CEO resigns to pursue other opportunities)
• $Beyond Air(XAIR.US)$ +6.4% (presents positive study update from the at-home LungF...
專欄Today's pre-market stock movers: STNE, ONON, USAS and more
In reaction to earnings/guidance:
• $StoneCo(STNE.US)$ +28.4% (also announces executive hires), $昂跑(ONON.US)$ +8.27%, $美洲白銀公司(USAS.US)$ +3.85%, $Torrid(CURV.US)$ +0.8%
Other news:
• $萊斯康製藥(LXRX.US)$ +4.5% (enters into loan facility to support commercialization of sotagliflozin)
• $TMC the metals(TMC.US)$ +3.2% (signs term sheet for development of commercial system to collect deep-sea pol...
Should’ve bought more
暫無評論